Previous close | 103.75 |
Open | 104.00 |
Bid | N/A x N/A |
Ask | N/A x N/A |
Day's range | 102.75 - 105.05 |
52-week range | 75.45 - 120.66 |
Volume | |
Avg. volume | 481,091 |
Market cap | 27.59B |
Beta (5Y monthly) | N/A |
PE ratio (TTM) | N/A |
EPS (TTM) | -2.82 |
Earnings date | N/A |
Forward dividend & yield | 2.50 (2.41%) |
Ex-dividend date | 09 May 2024 |
1y target est | 119.30 |
NEW YORK, April 04, 2024 (GLOBE NEWSWIRE) -- OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced DSM Firmenich AG (Euronext Amsterdam: DSFIR; OTCQX: DSFIY, DSMFF), a leading innovator in nutrition, health, and beauty, has qualified to trade on the OTCQX® Best Market. DSM Firmenich AG upgraded to OTCQX from the Pink® Limited market. DSM Firmenich AG begins trading today on OTCQX under the symbols “DSFIY and DSMF
Key Insights Significant control over DSM-Firmenich by retail investors implies that the general public has more power...
Key Insights Using the 2 Stage Free Cash Flow to Equity, DSM-Firmenich fair value estimate is €114 With €91.43 share...